We are live on ! Find out more
ANTX icon

AN2 Therapeutics
ANTX

51 hedge funds and large institutions have $418M invested in AN2 Therapeutics in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 2

60% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 10

38% more funds holding

Funds holding: 37 → 51 (+14)

30% more capital invested

Capital invested by funds: $320M → $418M (+$97.7M)

1.49% more ownership

Funds ownership: 67.09% → 68.58% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
51
Holders Change
+14
Holders Change %
+37.84%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
16
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.41M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$3.14M
3
ACP
Acuta Capital Partners
California
+$1.99M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.89M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.49M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$6.35M
2
OCA
Octagon Capital Advisors
New York
-$3.4M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.82M
4
NCM
Nantahala Capital Management
Connecticut
-$1.82M
5
MIM
Monashee Investment Management
Massachusetts
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Laurion Capital Management
New York
$898K +$733K +43,814 New
Millennium Management
27
Millennium Management
New York
$813K +$664K +39,674 New
Deutsche Bank
28
Deutsche Bank
Germany
$809K +$660K +39,472 New
State Street
29
State Street
Massachusetts
$785K +$383K +22,900 +149%
BCM
30
Bridgeway Capital Management
Texas
$758K -$176K -10,508 -22%
MIM
31
Monashee Investment Management
Massachusetts
$697K -$1.1M -65,498 -66%
Northern Trust
32
Northern Trust
Illinois
$677K +$275K +16,415 +99%
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$587K – – –
ECM
34
ExodusPoint Capital Management
New York
$530K +$432K +25,842 New
TD Asset Management
35
TD Asset Management
Ontario, Canada
$529K +$432K +25,800 New
Bank of America
36
Bank of America
North Carolina
$449K +$315K +18,799 +607%
Balyasny Asset Management
37
Balyasny Asset Management
Illinois
$395K +$323K +19,285 New
Two Sigma Investments
38
Two Sigma Investments
New York
$394K +$322K +19,248 New
Man Group
39
Man Group
United Kingdom
$376K +$307K +18,337 New
CSS
40
Cubist Systematic Strategies
Connecticut
$338K +$276K +16,483 New
Goldman Sachs
41
Goldman Sachs
New York
$288K +$235K +14,046 New
6CM
42
683 Capital Management
New York
$274K +$224K +13,392 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$202K +$165K +9,842 New
Morgan Stanley
44
Morgan Stanley
New York
$137K +$64.9K +3,877 +139%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$13.7K – – –
PAS
46
Point72 Asia (Singapore)
Singapore
$12.7K +$10.4K +621 New
Osaic Holdings
47
Osaic Holdings
Arizona
$6.15K +$1.67K +100 +50%
Federated Hermes
48
Federated Hermes
Pennsylvania
$5.29K +$2.68K +160 +163%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$5.12K – – –
Wells Fargo
50
Wells Fargo
California
$2.58K +$1.07K +64 +103%
1
2
3

ANTX Hedge Fund Activity: Q4 2023 in Review

51 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AN2 Therapeutics (ANTX) for Q4 2023, worth a combined $418M — up 30% from $320M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ANTX positions and 2 closed out — a net gain of 14 holders — while 16 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $4.41M. The largest seller was Marshall Wace, cutting an estimated $6.35M.

  • 51 institutional investors held AN2 Therapeutics (ANTX) as of Q4 2023, up from 37 in Q3 2023.
  • Funds reported $418M of AN2 Therapeutics stock for Q4 2023, up 30% quarter-over-quarter.
  • 16 funds opened new AN2 Therapeutics positions in Q4 2023 and 2 closed out, a net change of +14 holders.
  • The largest AN2 Therapeutics buyer in Q4 2023 was BlackRock, an estimated $4.41M added.
  • The largest AN2 Therapeutics seller in Q4 2023 was Marshall Wace, an estimated $6.35M sold.

Based on aggregated 13F filings for Q4 2023.